Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription 21.06.2021 2 AJR Am J Roentgenol 1 Am J Clin Pathol 1 Ann Thorac Surg 1 Cancer Sci 1 Chest 1 Clin Lung Cancer 1 Eur J Cardiothorac Surg 1 Lancet Oncol 6 Lung Cancer

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. CHELALA L, Hossain R, Kazerooni EA, Christensen JD, et al
   Lung-RADS Version 1.1: Challenges and a Look Ahead, From the AJR Special Series on Radiology Reporting and Data Systems.
   AJR Am J Roentgenol. 2021;216:1411-1422.
   PubMed         Abstract available
   
   
2. ARAUJO-FILHO JAB, Halpenny D, McQuade C, Puthoff G, et al
   Management of Pulmonary Nodules in Oncologic Patients: AJR Expert Panel Narrative Review.
   AJR Am J Roentgenol. 2021;216:1423-1431.
   PubMed         Abstract available
   
   

   
   Am J Clin Pathol

3. HUPP MM, Khan S, Dincer HE, Mallery JS, et al
   Evaluation and Comparison of Performance Parameters and Impact of Telepathology and Operator Experience on Endobronchial and Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
   Am J Clin Pathol. 2021;155:755-765.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

4. PATEL DC, Leipzig M, Jeffrey Yang CF, Wang Y, et al
   Early Discharge after Lobectomy for Lung Cancer does not Equate to Early Readmission.
   Ann Thorac Surg. 2021 Jun 11. pii: S0003-4975(21)01012.
   PubMed         Abstract available
   
   

   
   Cancer Sci

5. WANG H, Jiang X, Cheng Y, Ren H, et al
   MZT2A promotes NSCLC viability and invasion by increasing Akt phosphorylation via the MOZART2 domain.
   Cancer Sci. 2021;112:2210-2222.
   PubMed         Abstract available
   
   

   
   Chest

6. GUINDE J, Bourdages-Pageau E, Collin-Castonguay MM, Laflamme L, et al
   A Prediction Model to Optimize Invasive Mediastinal Staging Procedures for Non-Small Cell Lung Cancer in Patients with a Radiologically Normal Mediastinum: the Quebec Prediction Model.
   Chest. 2021 Jun 10. pii: S0012-3692(21)01103-X. doi: 10.1016/j.chest.2021.
   PubMed         Abstract available
   
   

   
   Clin Lung Cancer

7. LEAL JL, Alexander M, Itchins M, Wright GM, et al
   EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer.
   Clin Lung Cancer. 2021 May 16. pii: S1525-7304(21)00093.
   PubMed         Abstract available
   
   

   
   Eur J Cardiothorac Surg

8. NOJIRI T, Inoue M, Maeda H, Takeuchi Y, et al
   Retraction to 'Low-dose human atrial natriuretic peptide for the prevention of postoperative cardiopulmonary complications in chronic obstructive pulmonary disease patients undergoing lung cancer surgery'.
   Eur J Cardiothorac Surg. 2021;59:1352.
   PubMed        
   
   

   
   Lancet Oncol

9. GAINOR JF, Curigliano G, Kim DW, Lee DH, et al
   Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
   Lancet Oncol. 2021 Jun 9. pii: S1470-2045(21)00247.
   PubMed         Abstract available
   
   

   
   Lung Cancer

10. GOKER E, Altwairgi A, Al-Omair A, Tfayli A, et al
    Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations.
    Lung Cancer. 2021;158:60-73.
    PubMed         Abstract available
    
    
11. QI M, Bian D, Zhang J, Zhu X, et al
    The modification of T description according to visceral pleural invasion and tumor size from 3.1cm to 4.0cm in non-small cell lung cancer: A retrospective analysis based on the SEER database.
    Lung Cancer. 2021;158:47-54.
    PubMed         Abstract available
    
    
12. OSAROGIAGBON RU
    The future in the instant: The lung adenocarcinoma classification as a predictor of future adverse events.
    Lung Cancer. 2021;155:191-192.
    PubMed        
    
    
13. WANG Z, Zhao J, Ma Z, Cui J, et al
    Corrigendum to "A phase 2 study of tislelizumab in combination with platinum-based chemotherapy as first-line treatment for advanced lung cancer in Chinese patients" [Lung Cancer 147 (2020) 259-268].
    Lung Cancer. 2021 Jun 11. pii: S0169-5002(21)00426.
    PubMed        
    
    
14. BORG M, Wen SWC, Nederby L, Hansen TF, et al
    Performance of the EarlyCDT(R) Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort.
    Lung Cancer. 2021;158:85-90.
    PubMed         Abstract available
    
    
15. LIU L, Bai H, Seery S, Li S, et al
    Efficacy and safety of treatment modalities across EGFR selected/unselected populations with non-small cell lung cancer and brain metastases: A systematic review and Bayesian network meta-analysis.
    Lung Cancer. 2021;158:74-84.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: